US Patent 11834660 Compositions for modulating Ataxin 2 expression
Patent 11834660 was granted and assigned to Ionis Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+66 properties)
Article (+389 characters)
US Patent 11834660 Compositions for modulating Ataxin 2 expression
Article
Patent abstract
Disclosed herein are antisense compounds and methods for decreasing Ataxin 2 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate Ataxin 2 associated diseases, disorders, and conditions. Such Ataxin 2 associated diseases include spinocerebellar ataxia type 2 (SCA2), amyotropic sclerosis (ALS), and parkinsonism.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
C. Frank Bennett0
Gene Hung0
Susan M. Freier0
Date of Patent
December 5, 2023
0Patent Application Number
173937380
Date Filed
August 4, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11834660 Compositions for modulating Ataxin 2 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.